Days after treatment | Control | Fluralaner | Efficacy (%)c | P valued | ||
---|---|---|---|---|---|---|
Mortality (%)a | 95% Confidence intervalb | Mortality (%)a | 95% Confidence intervalb | |||
1 | 12 (15) | 0.77–0.92 | 80 (100) | NAe | 100 | 0.0002* |
30 | 12 (15) | 0.77–0.92 | 80 (100) | NA | 100 | 0.0002* |
60 | 10 (12.5) | 0.80–0.94 | 80 (100) | NA | 100 | < 0.0001* |
90 | 11 (13.75) | 0.78–0.93 | 80 (100) | NA | 100 | < 0.0001* |
120 | 12 (15) | 0.77–0.92 | 80 (100) | NA | 100 | 0.0002* |
150 | 11 (13.75) | 0.78–0.93 | 80 (100) | NA | 100 | < 0.0001* |
180 | 11 (13.75) | 0.77–0.92 | 58 (72.5) | 0.17–0.37 | 68.1 | 0.0015* |
210 | 11 (13.75) | 0.78–0.93 | 50 (62.5) | 0.26–0.48 | 56.5 | 0.0049* |
240 | 10 (12.5) | 0.80–0.94 | 49 (61.25) | 0.28–0.49 | 55.7 | 0.0022* |
270 | 12 (15) | 0.77–0.92 | 40 (50) | 0.39–0.60 | 41.2 | 0.0171* |
300 | 12 (15) | 0.77–0.92 | 34 (42.5) | 0.46–0.68 | 32.3 | 0.0590 |
330 | 12 (15) | 0.77–0.92 | 19 (23.75) | 0.66–0.85 | 10.3 | 0.0301 |
360 | 11 (13.75) | 0.78–0.93 | 12 (15) | 0.77–0.92 | 1.4 | 1.0000 |